Pinsent Masons advises Bryan, Garnier & Co on Heidelberg Pharma AG’s capital increase
28 Jun 2021 | 02:23 pm |
Multinational law firm Pinsent Masons has advised Bryan, Garnier & Co on the successful EUR 20m capital increase of Heidelberg Pharma AG.
The transaction increased German based biopharmaceutical company Heidelberg Pharma AG’s share capital by approximately 10%, with the 3,106,637 newly issued shares offered to qualified institutional investors in Europe and the United States in an accelerated book-building process. At a subscription price of EUR 6.44 per share, the company raised gross proceeds of EUR 20 million.
The new shares were admitted to trading on the Frankfurt Stock Exchange on June 21, 2021.
Pinsent Masons advised Bryan, Garnier & Co, the sole global coordinator and sole bookrunner for the transaction. Bryan, Garnier & Co is one of the most active investment banks in the European growth sector, with a particular focus on healthcare, technology, consumer goods and business services. They are a fully registered broker-dealer, licensed and supervised by the FCA in Europe and FINRA in the US.
The Pinsent Masons team was led by Dr Susanne Lenz, LL.M. and included Roberta Markovina (Partner, London), Dušan Stojković (Senior Associate, Frankfurt) and Sara Šepac (Associate, Frankfurt).
Commenting on the transaction, Dr Susanne Lenz said:
"We are pleased to have worked with Bryan Garnier on this exciting and important transaction. With Heidelberg Pharma AG’s expertise in oncology, we are proud to have been part of the successful financing of a company on the cutting edge of biopharmaceutical research and development in Germany."
Latest press releases
Show me all press releasesPinsent Masons advises NTR to secure refinancing of Provencialis wind farm (48 MW) in France
Pinsent Masons has advised Irish-based renewables investor and asset manager NTR, acting as sponsor on the successful refinancing of the French wind farm Provencialis, with an installed capacity of 48 MW
Pinsent Masons advises trustee on Videndum DB Pension Scheme transfer to Clara
Multinational law firm Pinsent Masons has advised the Trustee of the Videndum DB Pension Scheme on a bulk transfer of members and assets to Clara, the UK’s only authorised defined benefit pensions superfund.
Pinsent Masons advises Rolls Royce SMR on £599m National Wealth Fund loan facility to accelerate Small Modular Reactor programme
Pinsent Masons has advised Rolls Royce SMR on securing up to £599 million of co-funding facility from the UK’s National Wealth Fund, supporting the generic design development of its Small Modular Reactor (SMR) technology.
People who viewed this press release also viewed
Show me all press releasesPinsent Masons advises NTR to secure refinancing of Provencialis wind farm (48 MW) in France
Pinsent Masons has advised Irish-based renewables investor and asset manager NTR, acting as sponsor on the successful refinancing of the French wind farm Provencialis, with an installed capacity of 48 MW
Pinsent Masons MPillay advises Asian Development Bank on funding of submarine cable connecting Vanuatu and New Caledonia
Pinsent Masons MPillay has advised the Asian Development Bank (ADB) on the financing for the design, construction and installation of a 411-kilometre submarine cable connecting the Pacific nations of Vanuatu and New Caledonia.
Pinsent Masons advises IFC on landmark investment to boost Retail sector in Senegal
Multinational law firm Pinsent Masons has advised International Finance Corporation (IFC), a member of the World Bank Group and the largest global development institution focused on the private sector in emerging markets, on its landmark investment of €25 million in Groupe EDK, Senegal’s foremost retail and large-scale distribution operator.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]